301 related articles for article (PubMed ID: 6235248)
1. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
Booth NA; Anderson JA; Bennett B
J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
[TBL] [Abstract][Full Text] [Related]
2. Methods for studying fibrinolytic pathway components in human plasma.
Wohl RC; Sinio L; Robbins KC
Thromb Res; 1982 Sep; 27(5):523-35. PubMed ID: 6217585
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an active fibrinolytic system in normal human bone marrow.
McWilliam NA; Robbie LA; Barelle CJ; Adey G; Prasad S; Bennett B; Booth NA
Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456
[TBL] [Abstract][Full Text] [Related]
4. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
6. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N; Moroi M; Matsuda M; Tachiya K
J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
[TBL] [Abstract][Full Text] [Related]
7. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
[TBL] [Abstract][Full Text] [Related]
8. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
10. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
Booth NA; Bennett B
Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
[TBL] [Abstract][Full Text] [Related]
11. Lower molecular weight species of alpha 2-macroglobulin-plasmin complexes in human plasma activated by urokinase.
Yamamoto J; Okamoto U
Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1090-9. PubMed ID: 2414954
[No Abstract] [Full Text] [Related]
12. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
Booth NA; Anderson JA; Bennett B
Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
[TBL] [Abstract][Full Text] [Related]
13. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination.
Bennett B; Booth NA; Croll A; Dawson AA
Br J Haematol; 1989 Apr; 71(4):511-7. PubMed ID: 2496742
[TBL] [Abstract][Full Text] [Related]
14. The fibrinolytic system in human ascites.
Buø L; Karlsrud TS; Dyrhaug G; Bell H; Engström L; Johansen HT; Aasen AO
Scand J Gastroenterol; 1995 Nov; 30(11):1101-7. PubMed ID: 8578171
[TBL] [Abstract][Full Text] [Related]
15. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
Gissler HM; Frank R; Kramer MD
Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
[TBL] [Abstract][Full Text] [Related]
17. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.
; ; . PubMed ID: 1485607
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
